Spotlight on Hidradenitis Suppurativa: A Review of New 4-year Data on Secukinumab in HS, Plus More With Dr. Martina Porter
Martina Porter, MD, takes a deep dive into new four-year data on continuous treatment with secukinumab in patients with hidradenitis suppurativa (HS).